{"id":"NCT01052844","sponsor":"Faculdade de Medicina do ABC","briefTitle":"Gabapentin in the Prevention of Nausea and Vomiting Induced by Chemotherapy","officialTitle":"Clinical Trial of Gabapentin in the Prevention of Nausea Ond Vomiting Induced by Chemotherapy, a Randomized, Double-blind, Placebo Controled Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-01","primaryCompletion":"2010-07","completion":"2010-07","firstPosted":"2010-01-20","resultsPosted":"2014-03-07","lastUpdate":"2014-03-07"},"enrollment":80,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Vomiting","Cisplatin Adverse Reaction"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Gabapentin","otherNames":[]}],"arms":[{"label":"Control group","type":"PLACEBO_COMPARATOR"},{"label":"Gabapentin","type":"EXPERIMENTAL"}],"summary":"Gabapentin is an antiepileptic drug. Its antiemetic effect is demonstrated after laparoscopic surgery, but it is not yet known whether gabapentin is effective in preventing chemotherapy induced emesis.\n\nThe purpose of this study is to determine whether the addition of gabapentin to dexamethasone plus ondansetron increase the control of chemotherapy-induced nausea and vomiting.","primaryOutcome":{"measure":"Number of Patients With Complete Response During Chemotherapy Course 1","timeFrame":"5 days","effectByArm":[{"arm":"Control Group","deltaMin":17,"sd":null},{"arm":"Gabapentin","deltaMin":26,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.04"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":6},"locations":{"siteCount":1,"countries":["Brazil"]},"refs":{"pmids":["21465325"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":40},"commonTop":["Xerostomia","Sleepiness","Dizziness","Constipation","Heartburn"]}}